|
Receipt of R&D Tax Incentive Refund
|
30 June 2023 at 12:50pm
|
|
Updated HepaFatSmart Cleared by US FDA
|
29 June 2023 at 11:25am
|
|
Management Transition
|
23 June 2023 at 8:40am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 April 2023 at 2:10pm
|
|
Director Appointment & Appendix 3X
|
28 March 2023 at 8:30am
|
|
Change of Director's Interest Notice
|
22 March 2023 at 8:35am
|
|
Half Yearly Report and Accounts
|
28 February 2023 at 4:50pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2023 at 10:55am
|
|
Change of Director's Interest Notice
|
5 January 2023 at 5:25pm
|
|
MRI Fibrosis Provisional Patent Application Lodged
|
21 December 2022 at 10:20am
|
|
Notification of cessation of securities - RHT
|
2 December 2022 at 8:45am
|
|
Notification of cessation of securities - RHT
|
28 November 2022 at 6:45pm
|
|
Notification of cessation of securities - RHT
|
28 November 2022 at 3:50pm
|
|
Results of Meeting
|
24 November 2022 at 2:45pm
|
|
Investor Presentation
|
24 November 2022 at 12:10pm
|
|
Resonance Health Contracted for Two New Clinical Trials
|
11 November 2022 at 8:35am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 October 2022 at 1:20pm
|
|
Resonance Health Launches Resonance Clinical
|
25 October 2022 at 11:40am
|
|
Notice of Annual General Meeting/Proxy Form
|
21 October 2022 at 8:40am
|
|
2022 AGM Notification of Dates
|
7 October 2022 at 8:35am
|
|
Appendix 4G and Corporate Governance Statement
|
30 September 2022 at 8:35am
|
|
Annual Report to shareholders
|
30 September 2022 at 8:35am
|
|
Preliminary Final Report
|
30 August 2022 at 4:35pm
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 July 2022 at 4:59pm
|
|
FerriScan Now Available on 3 Tesla (3T) MRI Machines
|
25 July 2022 at 8:35am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
2 May 2022 at 8:10am
|
|
Company Secretary Appointment/Resignation
|
29 April 2022 at 7:25pm
|
|
Investor Presentation April 2022
|
6 April 2022 at 1:30pm
|
|
Platform Integration & Partnership Agreement with CARPL.ai
|
5 April 2022 at 8:50am
|
|
Half Yearly Report and Accounts
|
28 February 2022 at 8:15am
|
|
US CPT Code Confirmation for LiverSmart
|
7 February 2022 at 10:50am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 January 2022 at 8:50am
|
|
Resonance Health Enters China - Pharma Contract Signed
|
27 January 2022 at 3:05pm
|
|
Resonance Health Contracted for Third Party Clinical Trial
|
25 January 2022 at 8:45am
|
|
Change in substantial holding
|
18 January 2022 at 12:50pm
|
|
US FDA Clearance for LiverSmart
|
30 December 2021 at 10:30am
|
|
ASO Project New Data
|
20 December 2021 at 10:30am
|
|
LiverSmart Submitted to FDA for US Regulatory Clearance
|
3 December 2021 at 9:45am
|
|
Jobkeeper Announcement
|
29 November 2021 at 8:50am
|
|
Results of Meeting
|
25 November 2021 at 3:30pm
|
|
Investor Presentation - Positioning for Growth
|
25 November 2021 at 12:25pm
|
|
Appointment of CMO - Professor John Olynyk
|
24 November 2021 at 8:35am
|
|
ASO R&D Project - Filing of Two Patent Applications
|
23 November 2021 at 8:45am
|
|
Thalassaemia International Federation to Deploy FerriSmart
|
12 November 2021 at 8:50am
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 October 2021 at 8:30am
|
|
Notice of Annual General Meeting/Proxy Form
|
25 October 2021 at 8:35am
|
|
Sales & Marketing Update
|
14 October 2021 at 8:45am
|
|
New AI Medical Device
|
13 October 2021 at 8:50am
|
|
AGM Date and Director Nomination Closing Date
|
7 October 2021 at 8:50am
|
|
Appendix 4G and Corporate Governance Statement
|
30 September 2021 at 8:25am
|
Resonance Health